Klemann, C., Esquivel, M., Magerus-Chatinet, A., Lorenz, M. R., Fuchs, I., Neveux, N., Castelle, M., Rohr, J., da Cunha, C. B., Ebinger, M., Kobbe, R., Kremens, B., Kollert, F., Gambineri, E., Lehmberg, K., Seidel, M. G., Siepermann, K., Voelker, T., Schuster, V., Goldacker, S., Schwarz, K., Speckmann, C., Picard, C., Fischer, A., Rieux-Laucat, F., Ehl, S., Rensing-Ehl, A. and Neven, B. (2017) “Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome”, Haematologica. Pavia, Italy, 102(2), pp. e52-e56. doi: 10.3324/haematol.2016.153411.